by support | Nov 20, 2025 | Uncategorized
🎁 This Holiday Season, Give Hope. Give Connection. Give to NTMir. As the year comes to a close, we’re reflecting on how far we’ve come — and how your generosity continues to make it all possible. In 2025, the impossible became reality: the first-ever FDA-approved...
by support | Oct 20, 2025 | Blogs
🫁 Myth vs. Fact: Understanding NTM Lung Disease What Is NTM Lung Disease? Nontuberculous Mycobacterial (NTM) lung disease is a chronic infection caused by bacteria commonly found in water and soil. These bacteria are everywhere — in showerheads, household plumbing,...
by support | Oct 20, 2025 | Blogs
🫁 Understanding Rare Lung Diseases: Why Awareness Saves Lives Breathing Shouldn’t Be a Struggle Most of us don’t think twice about breathing — until something makes it difficult. For people living with rare lung diseases, every breath can be a reminder of how fragile...
by support | Oct 16, 2025 | Blogs
MAC is NTM: Understanding the Connection Between These Two Terms Many patients newly diagnosed with a mycobacterial lung infection are often confused by the terminology used. You may have heard your doctor mention “MAC” or “NTM” — sometimes interchangeably — and...
by support | Aug 12, 2025 | Blogs
BRINSUPRI™ (brensocatib) Becomes First FDA-Approved Treatment for Bronchiectasis August 12, 2025 marks a new chapter in care for patients worldwide Tuesday, August 12, 2025, is a monumental day for the bronchiectasis community. The U.S. Food and Drug Administration...
